These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26950991)

  • 1. [COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES].
    Chernikova MI; Kashirina OS; Vasiliev YM
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):63-71. PubMed ID: 26950991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increasing the immunogenicity of inactivated chitosan adjuvanted vaccine from A/California/7/09 (H1N1) strain and analyzing the antigenic specificity of this influenza virus strain].
    Gendon IuZ; Markushin SG; Vasil'ev IuM; Akopova II; Krivtsov GG
    Vopr Virusol; 2012; 57(1):28-33. PubMed ID: 22624470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chitosan as an adjuvant for parenteral inactivated influenza vaccines].
    Gendon IuZ; Markushin SG; Krivtsov GG; Akopova II
    Vopr Virusol; 2008; 53(5):14-9. PubMed ID: 19069787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems.
    Precioso AR; Miraglia JL; Campos LM; Goulart AC; Timenetsky Mdo C; Cardoso MR; Luna E; Mondini G; Guedes Jda S; Raw I
    Vaccine; 2011 Nov; 29(48):8974-81. PubMed ID: 21945258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H; Bao Y; Wang X; Zhou D; Wu W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.
    Morçӧl T; Hurst BL; Tarbet EB
    Vaccine; 2017 Aug; 35(35 Pt B):4569-4577. PubMed ID: 28716554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice.
    Ramirez A; Co M; Mathew A
    PLoS One; 2016; 11(3):e0150425. PubMed ID: 26934728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan].
    Kydyrbaev ZhK; Mamadaliev SM; Asanzhanova NN; Tabynov KK; Ryskel'dinova ShZh; Cherviakova OV; Sandybaev NT; Khaĭrullin BM; Kiselev OI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):54-9. PubMed ID: 23163037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
    Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
    J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
    Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants.
    Dehghan S; Tafaghodi M; Bolourieh T; Mazaheri V; Torabi A; Abnous K; Tavassoti Kheiri M
    Int J Pharm; 2014 Nov; 475(1-2):1-8. PubMed ID: 25148732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine.
    Uraki R; Das SC; Hatta M; Kiso M; Iwatsuki-Horimoto K; Ozawa M; Coban C; Ishii KJ; Kawaoka Y
    Vaccine; 2014 Sep; 32(41):5295-300. PubMed ID: 25108216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenicity of inactivated subunit adsorbed monovalent vaccine against influenza A/California/7/2009 (H1N1) strain].
    Zverev VV; Kostinov MP; Mikhailova NA; Zhirova SN; Mironov AN; Terkacheva OA; Romanova AA; Cherdantsev AP
    Vopr Virusol; 2011; 56(3):20-3. PubMed ID: 21786622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice.
    Xu W; Zheng M; Zhou F; Chen Z
    Clin Vaccine Immunol; 2015 Mar; 22(3):327-35. PubMed ID: 25589552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
    Miyaki C; Quintilio W; Miyaji EN; Botosso VF; Kubrusly FS; Santos FL; Iourtov D; Higashi HG; Raw I
    Vaccine; 2010 Mar; 28(13):2505-9. PubMed ID: 20123051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic Poly(Amino Acid) Vaccine Adjuvant for Promoting Both Cell-Mediated and Humoral Immunity Against Influenza Virus.
    Lim JW; Na W; Kim HO; Yeom M; Park G; Kang A; Chun H; Park C; Oh S; Le VP; Jeong HH; Song D; Haam S
    Adv Healthc Mater; 2019 Jan; 8(2):e1800953. PubMed ID: 30549426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.